TRIM31 Antikörper (AA 131-230)
Kurzübersicht für TRIM31 Antikörper (AA 131-230) (ABIN715931)
Target
Alle TRIM31 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 131-230
-
Verwendungszweck
- TRIM31 Polyclonal Antibody
-
Homologie
- Human
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human TRIM31
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:300-5000),
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
-
: "Identification of hub genes and pathways associated with bladder cancer based on co-expression network analysis." in: Oncology letters, Vol. 14, Issue 1, pp. 1115-1122, (2017) (PubMed).
-
-
- TRIM31 (Tripartite Motif Containing 31 (TRIM31))
-
Andere Bezeichnung
- Trim31
-
Hintergrund
-
Synonyms: C6orf13, H.sapiens mRNA for RING protein, HCG1, HCGI, Ring finger protein, RNF, Tripartite mot containing protein 31, TRI31_HUMAN.
Background: The TRIM motif includes three zinc binding domains, a RING, a B box type 1 and a B box type 2, and a coiled-coil region. The protein localizes to both the cytoplasm and the nucleus. Its function has not been identified.
-
Gen-ID
- 11074
Target
-